The aim of the paper is to determine the risk level of a contract extension with the existing policyholders, which is further propagated to the business effectiveness and long-term sustainability of the company. The uncertainties in the relative importance of risk factors, their values, and risk levels are described by the linguistic forms, which are modeled by using the fuzzy sets theory. The evaluations of the relative importance of risk factors are stated as a fuzzy group decision-making problem. The weights of risk factors are obtained by using a fuzzy analytic hierarchy process. The determination of production rules for the assessment of the risk level is based on fuzzy IF-THAN rules. The verification of the model is performed by using real-life data originating from the insurance company which operates in the Republic of Serbia.
Corporate and organizational performance assessment is an important activity for both the managers and other stakeholders, as it provides them with an asset to evaluate their own strengths and weaknesses in relation to the competition, as well as guidelines for selecting appropriate measures to address the existing problems. The issue of criteria selection has been overcome through the literature review and the issue of criteria weights is handled by applying group decision making procedure. The procedure itself consists of using predefined linguistic expressions that are modelled by triangular fuzzy numbers and the aggregation of decision makers' opinion based on the rules of rough sets algebra. The values of the decision matrix are determined by prognosis method and they are described by crisp values. The proposed algorithm is tested on the insurance companies that operate in the Republic of Serbia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.